Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2002
Business Overview: ASHS provides Gamma Knife radiosurgery units to medical centers through its majority-owned subsidiary, GK Financing, LLC. As of June 30, 2002, the Company operated 13 Gamma Knife units across 12 states. Revenue models include fee-per-use contracts and revenue-sharing ("retail") agreements.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2002 | Six Months Ended June 30, 2002 | Balance Sheet (June 30, 2002) |
|---|---|---|---|
| Revenue | $3,216,000 | $6,461,000 | N/A |
| Net Income | $311,000 | $631,000 | N/A |
| Earnings Per Share (Basic) | $0.08 | $0.17 | N/A |
| Operating Cash Flow | N/A | $1,684,000 | N/A |
| Cash and Equivalents | N/A | N/A | $10,018,000 |
| Total Debt (Current + Long-term) | N/A | N/A | $27,558,000 |
| Working Capital | N/A | N/A | $7,988,000 |
Material Changes vs. Prior Period
- Revenue Growth: Medical services revenue increased 14% for the six months ended June 30, 2002, compared to the prior year. This was driven by the addition of one new Gamma Knife unit in Q2 2002, the full six-month inclusion of two units added in Q2 2001, and increased procedure volumes at mature centers.
- Procedure Volume: The number of Gamma Knife procedures rose 14% to 804 for the six-month period, compared to 703 in the prior year.
- Expense Trends: Total costs of operations increased due to higher maintenance costs (warranty expirations), increased depreciation from new assets, and higher insurance/marketing costs. Selling and administrative costs rose primarily due to rent and professional fees, partially offset by reduced development costs for subsidiaries OR21 and MedLeader.
- Interest Expense: Interest expense decreased by $24,000 for the six-month period due to capitalized interest on future unit deposits and lower balances on mature loans, offsetting interest on new financing.
- Income Tax Benefit: Net income was significantly boosted by income tax benefits totaling $168,000 for the six-month period, resulting from the exercise of stock options granted in 1995.
Guidance, Outlook, and Risks
- Liquidity: The Company holds $10.0 million in cash and cash equivalents. Management believes cash flow from operations and existing resources are adequate to meet scheduled debt obligations of approximately $7.3 million due in the next 12 months.
- Capital Allocation: Cash is invested in an institutionally priced money market fund. The Company paid annual dividends of $0.12 per share ($438,000 total) in March 2002.
- Accounting Changes: The Company noted the adoption of new FASB statements (SFAS 141, 142, 143, 144) regarding business combinations, goodwill, asset retirement obligations, and impairment. Management does not expect these to have a material effect on financial position.
- Legal Proceedings: No material legal proceedings were reported.
Investor Verification Checklist
- Revenue Concentration: Verify the mix of fee-per-use versus revenue-sharing contracts, as the latter exposes the Company to operating expense risks.
- Debt Service Coverage: Confirm that operating cash flows remain sufficient to cover the $7.3 million in scheduled debt payments over the next 12 months.
- Tax Benefit Sustainability: Note that the significant increase in net income was partially driven by non-recurring tax benefits from historical stock option exercises; future earnings may not reflect similar tax advantages.
- Asset Expansion: Monitor the deployment of new Gamma Knife units and the associated capital expenditures required to maintain growth.